Article info
PDFSham neurosurgery in patients with Parkinson's disease: is it morally acceptable?
Citation
Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?
Publication history
- First published June 1, 2001.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2001 by the Journal of Medical Ethics
Other content recommended for you
- Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls
- Sham surgery controls are mitigated trolleys
- Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
- Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s disease
- Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease
- Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease
- Sham surgery can be ethical and safe
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease